Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial (Q40572857)

10 January 2018

title

Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial (English)

1 reference

10 January 2018

main subject

prevention of HIV/AIDS

0 references

author

Estelle Piwowar-Manning

8

Estelle Piwowar-Manning

1 reference

10 January 2018

29

Beatriz Grinsztejn

1 reference

10 January 2018

33

Myron S Cohen

1 reference

10 January 2018

4

Ronald Swanstrom

1 reference

PMCID

5140698

Nagalingeswaran Kumarasamy

10 January 2018

25

Nagalingeswaran Kumarasamy

1 reference

10 January 2018

18

Thomas C Quinn

1 reference

10 January 2018

1

Susan H Eshleman

1 reference

10 January 2018

Kenneth Mayer

30

Kenneth Mayer

1 reference

10 January 2018

0 references

23

Sikhulile Moyo

1 reference

10 January 2018

Jessica M Fogel

16

Jessica M Fogel

1 reference

10 January 2018

Stephen F Porcella

9

Stephen F Porcella

1 reference

10 January 2018

Marybeth McCauley

14

Marybeth McCauley

1 reference

10 January 2018

Theresa Gamble

15

Theresa Gamble

1 reference

10 January 2018

Jose Henrique Pilotto

28

Jose Pilotto

1 reference

10 January 2018

Ravindre Panchia

24

Ravindre Panchia

1 reference

10 January 2018

Sarah E Hudelson

2

Sarah E Hudelson

1 reference

10 January 2018

Craig C Martens

11

Craig A Martens

1 reference

10 January 2018

Devin Sabin

17

Devin Sabin

1 reference

10 January 2018

Marineide Gonçalves de Melo

27

Marineide Gonçalves de Melo

1 reference

10 January 2018

Victor Akelo

22

Victor Akelo

1 reference

10 January 2018

Nuntisa Chotirosniramit

26

Nuntisa Chotirosniramit

1 reference

10 January 2018

Daniel Bruno

12

Daniel Bruno

1 reference

10 January 2018

author name string

Andrew D Redd

3

1 reference

10 January 2018

San-San Ou

5

1 reference

10 January 2018

Xinyi Cindy Zhang

6

1 reference

10 January 2018

Li-Hua Ping

7

1 reference

10 January 2018

Matthew F Sievers

10

1 reference

10 January 2018

Elena Dukhovlinova

13

1 reference

10 January 2018

Laurence Gunde

19

1 reference

10 January 2018

Madalitso Maliwichi

20

1 reference

10 January 2018

Nehemiah Nhando

21

1 reference

10 January 2018

Ying Q Chen

31

1 reference

10 January 2018

James P Hughes

32

1 reference

10 January 2018

language of work or name

English

0 references

publication date

16 August 2016

1 reference

10 January 2018

Journal of Acquired Immune Deficiency Syndromes

published in

1 reference

10 January 2018

volume

74

1 reference

10 January 2018

issue

1

1 reference

10 January 2018

page(s)

112-116

1 reference

10 January 2018

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5140698

Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: an implementation case study

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5140698

HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5140698

The impact of clinical, demographic and risk factors on rates of HIV transmission: a population-based phylogenetic analysis in British Columbia, Canada

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5140698

Heterosexual risk of HIV transmission per sexual act under combined antiretroviral therapy: systematic review and bayesian modeling

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5140698

Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5140698

HIV-1 transmission during early antiretroviral therapy: evaluation of two HIV-1 transmission events in the HPTN 052 prevention study

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5140698

Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052).

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5140698

Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventions

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5140698

Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5140698

Prevention of HIV-1 infection with early antiretroviral therapy

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5140698

Estimating time since infection in early homogeneous HIV-1 samples using a poisson model

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5140698

BEAST: Bayesian evolutionary analysis by sampling trees

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5140698

Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5140698

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5140698

Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5140698

Antiretroviral Therapy for the Prevention of HIV-1 Transmission

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27532476

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/QAI.0000000000001158

1 reference

10 January 2018

PMCID

5140698

1 reference

10 January 2018

PubMed ID

27532476

1 reference

10 January 2018